{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:43:26Z","timestamp":1791107006866,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1038\/nrmicro1707","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T11:55:24Z","timestamp":1184586924000},"page":"583-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":267,"title":["Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy"],"prefix":"10.1038","volume":"5","author":[{"given":"Jan","family":"Balzarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrmicro1707_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev. Immunol. 5, 215\u2013229 (2005).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro1707_CR2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nri1959","volume":"6","author":"NL Letvin","year":"2006","unstructured":"Letvin, N. L. Progress and obstacles in the development of an AIDS vaccine. Nature Rev. Immunol. 6, 930\u2013939 (2006).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro1707_CR3","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.191.11.1853","volume":"191","author":"GE Price","year":"2000","unstructured":"Price, G. E., Ou, R., Jiang, H., Huang, L. & Moskophidis, D. Viral escape by selection of cytotoxic T-cell-resistant variants in influenza A virus pneumonia. J. Exp. Med. 191, 1853\u20131867 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro1707_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrmicro975","volume":"2","author":"E De Clercq","year":"2004","unstructured":"De Clercq, E. Antivirals and antiviral strategies. Nature Rev. Microbiol. 2, 704\u2013720 (2004).","journal-title":"Nature Rev. Microbiol."},{"key":"BFnrmicro1707_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(05)70271-1","volume":"5","author":"J Balzarini","year":"2005","unstructured":"Balzarini, J. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect. Dis. 5, 726\u2013731 (2005). The first extensive description of the new concept that CBAs may have a dual mechanism of antiviral action, including an immune response in addition to a direct inhibitory effect on virus entry.","journal-title":"Lancet Infect. Dis."},{"key":"BFnrmicro1707_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0006-3495(01)76074-2","volume":"80","author":"THT Christlet","year":"2001","unstructured":"Christlet, T. H. T. & Veluraja, K. Database analysis of O-glycosylation sites in proteins. Biophys. J. 80, 952\u2013960 (2001).","journal-title":"Biophys. J."},{"key":"BFnrmicro1707_CR7","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","volume":"291","author":"A Helenius","year":"2001","unstructured":"Helenius, A. & Aebi, M. Intracellular functions of N-linked glycans. Science 291, 2364\u20132369 (2001).","journal-title":"Science"},{"key":"BFnrmicro1707_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409239709085144","volume":"32","author":"PM Rudd","year":"1997","unstructured":"Rudd, P. M. & Dwek, R. A. Glycosylation: heterogeneity and the 3D structure of proteins. Crit. Rev. Biochem. Mol. Biol. 32, 1\u2013100 (1997).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"BFnrmicro1707_CR9","first-page":"43","volume":"96","author":"RA Dwek","year":"1998","unstructured":"Dwek, R. A. Biological importance of glycosylation. Dev. Biol. Stand. 96, 43\u201347 (1998).","journal-title":"Dev. Biol. Stand."},{"key":"BFnrmicro1707_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3480001","volume":"348","author":"AJ Parodi","year":"2000","unstructured":"Parodi, A. J. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem. J. 348, 1\u201313 (2000).","journal-title":"Biochem. J."},{"key":"BFnrmicro1707_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00249-005-0035-5","volume":"35","author":"HL Bagger","year":"2006","unstructured":"Bagger, H. L., Fuglsang, C. C. & Westh, P. Hydration of a glycoprotein: relative water affinity of peptide and glycan moieties. Eur. Biophys. J. 35, 367\u2013371 (2006).","journal-title":"Eur. Biophys. J."},{"key":"BFnrmicro1707_CR12","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1242\/jcs.03225","volume":"119","author":"LW Ruddock","year":"2006","unstructured":"Ruddock, L. W. & Molinari, M. N-glycan processing in ER quality control. J. Cell Sci. 119, 4373\u20134380 (2006).","journal-title":"J. Cell Sci."},{"key":"BFnrmicro1707_CR13","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1086\/374746","volume":"187","author":"RA Ezekowitz","year":"2003","unstructured":"Ezekowitz, R. A. Role of the mannose-binding lectin in innate immunity. J. Infect. Dis. 187, S335\u2013S339 (2003).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro1707_CR14","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1016\/j.febslet.2006.10.009","volume":"580","author":"E van Liempt","year":"2006","unstructured":"van Liempt, E. et al. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett. 580, 6123\u20136131 (2006).","journal-title":"FEBS Lett."},{"key":"BFnrmicro1707_CR15","first-page":"161","volume":"6","author":"TL Chang","year":"2004","unstructured":"Chang, T. L. & Klotman, M. E. Defensins: natural anti-HIV peptides. AIDS Res. 6, 161\u2013168 (2004).","journal-title":"AIDS Res."},{"key":"BFnrmicro1707_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/08916930601061470","volume":"39","author":"EI Buzas","year":"2006","unstructured":"Buzas, E. I. et al. Carbohydrate recognition systems in autoimmunity. Autoimmunity 39, 691\u2013704 (2006).","journal-title":"Autoimmunity"},{"key":"BFnrmicro1707_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-4613-0415-9_17","volume":"408","author":"A Etzioni","year":"1996","unstructured":"Etzioni, A. Adhesion molecules in leukocyte endothelial interaction. Adv. Exp. Med. Biol. 408, 151\u2013157 (1996).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrmicro1707_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.41.7.1521","volume":"41","author":"MR Boyd","year":"1997","unstructured":"Boyd, M. R. et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41, 1521\u20131530 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro1707_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/828","volume":"5","author":"CA Bewley","year":"1998","unstructured":"Bewley, C. A. et al. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nature Struct. Biol. 5, 571\u2013578 (1998).","journal-title":"Nature Struct. Biol."},{"key":"BFnrmicro1707_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/jmbi.1999.2693","volume":"288","author":"F Yang","year":"1999","unstructured":"Yang, F. et al. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J. Mol. Biol. 288, 403\u2013412 (1999).","journal-title":"J. Mol. Biol."},{"key":"BFnrmicro1707_CR21","doi-asserted-by":"publisher","first-page":"34336","DOI":"10.1074\/jbc.M205909200","volume":"277","author":"I Botos","year":"2002","unstructured":"Botos, I. et al. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J. Biol. Chem. 277, 34336\u201334342 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0969-2126(01)00653-0","volume":"9","author":"CA Bewley","year":"2001","unstructured":"Bewley, C. A. Solution structure of a cyanovirin-N:Man \u03b11\u20132Man\u03b1 complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure 9, 931\u2013940 (2001).","journal-title":"Structure"},{"key":"BFnrmicro1707_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1124\/mol.59.5.949","volume":"59","author":"AJ Bolmstedt","year":"2001","unstructured":"Bolmstedt, A. J., O'Keefe, B. R., Shenoy, S. R., McMahon, J. B & Boyd, M. R. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59, 949\u2013954 (2001).","journal-title":"Mol. Pharmacol."},{"key":"BFnrmicro1707_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1006\/bbrc.1999.1749","volume":"265","author":"M Yamaguchi","year":"1999","unstructured":"Yamaguchi, M. et al. Isolation and characterization of a mannan-binding lectin from the freshwater Cyanobacterium (blue-green algae) Microcystis viridis. Biochem. Biophys. Res. Commun. 265, 703\u2013708 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrmicro1707_CR25","doi-asserted-by":"publisher","first-page":"29269","DOI":"10.1074\/jbc.M504642200","volume":"280","author":"DC Williams Jr","year":"2005","unstructured":"Williams, D. C. Jr, Lee, J. Y., Cai, M., Bewley, C. A. & Clore, G. M. Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from N-linked oligomannoside. J. Biol. Chem. 280, 29269\u201329276 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR26","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1021\/bi0205698","volume":"42","author":"HR Bokesch","year":"2003","unstructured":"Bokesch, H. R. et al. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Biochemistry 42, 2578\u20132584 (2003).","journal-title":"Biochemistry"},{"key":"BFnrmicro1707_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.chembiol.2004.04.010","volume":"11","author":"EW Adams","year":"2004","unstructured":"Adams, E. W. et al. Oligosaccharide and glycoprotein microassays as tools in HIV glycobiology: glycan-dependent gp120\/protein interactions. Chem. Biol. 11, 875\u2013881 (2004).","journal-title":"Chem. Biol."},{"key":"BFnrmicro1707_CR28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.18388\/abp.2006_3290","volume":"53","author":"NE Ziolkowska","year":"2006","unstructured":"Ziolkowska, N. E. & Wlodawer, A. Structural studies of algal lectins with anti-HIV activity. Acta Biochim. Pol. 53, 617\u2013626 (2006).","journal-title":"Acta Biochim. Pol."},{"key":"BFnrmicro1707_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1432-1033.1987.tb13585.x","volume":"169","author":"Z Kljajic","year":"1987","unstructured":"Kljajic, Z. et al. A D-mannose-specific lectin from Gerardia savaglia that inhibits nucleocytoplasmic transport of mRNA. Eur. J. Biochem. 169, 97\u2013104 (1987).","journal-title":"Eur. J. Biochem."},{"key":"BFnrmicro1707_CR30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1006\/bbrc.2001.4496","volume":"281","author":"J Inokoshi","year":"2001","unstructured":"Inokoshi, J. et al. Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli. Biochem. Biophys. Res. Commun. 281, 1261\u20131265 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrmicro1707_CR31","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1074\/jbc.M411122200","volume":"280","author":"T Mori","year":"2005","unstructured":"Mori, T. et al. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia spp. J. Biol. Chem. 280, 9345\u20139353 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR32","first-page":"453","volume":"1","author":"WE Muller","year":"1988","unstructured":"Muller, W. E., Renneisen, K., Kreute, M. H., Schroder, H. C. & Winkler, I. The D-mannose-specific lectin from Gerardia savaglia blocks binding of human immunodeficiency virus type 1 to H9 cells and human lymphocytes in vitro. J. Acquir. Immune Defic. Syndr. 1, 453\u2013458 (1988).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrmicro1707_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1006\/bbrc.2001.4495","volume":"282","author":"H Chiba","year":"2001","unstructured":"Chiba, H. et al. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities. Biochem. Biophys. Res. Commun. 282, 595\u2013601 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrmicro1707_CR34","volume-title":"Handbook of Plant Lectins: Properties and Biomedical Applications","author":"EJM Van Damme","year":"1998","unstructured":"Van Damme, E. J. M., Peumans, W. J., Pusztai, A. & Barocz, S. Handbook of Plant Lectins: Properties and Biomedical Applications (John Wiley & Sons, Chichester, New York, 1998)."},{"key":"BFnrmicro1707_CR35","volume-title":"Lectins","author":"N Sharon","year":"2003","unstructured":"Sharon, N. & Lis, H. (eds) Lectins 2nd edn (Kluwer Academic, Dordrecht, 2003)."},{"key":"BFnrmicro1707_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1006\/jmbi.1996.0532","volume":"262","author":"G Hester","year":"1996","unstructured":"Hester, G. & Wright C. S. The mannose-specific bulb lectin from Galanthus nivalis (snowdrop) binds mono- and dimannosides at distinct sites. Structure analysis of refined complexes at 2.3 \u00c5 and 3.0 \u00c5 resolution. J. Mol. Biol. 262, 516\u2013531 (1996).","journal-title":"J. Mol. Biol."},{"key":"BFnrmicro1707_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1006\/jmbi.2000.3594","volume":"297","author":"K Harata","year":"2000","unstructured":"Harata, K. & Muraki, M. Crystal structures of Urtica dioica agglutinin and its complex with tri-acetylchitotriose. J. Mol. Biol. 297, 673\u2013681 (2000).","journal-title":"J. Mol. Biol."},{"key":"BFnrmicro1707_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1128\/AAC.35.3.410","volume":"35","author":"J Balzarini","year":"1991","unstructured":"Balzarini, J. et al. \u03b1-(1\u20133)- and \u03b1-(1\u20136)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro. Antimicrob. Agents Chemother. 35, 410\u2013416 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro1707_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-3542(92)90038-7","volume":"18","author":"Balzarini","year":"1992","unstructured":"Balzarini et al. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res. 18, 191\u2013207 (1992).","journal-title":"Antiviral Res."},{"key":"BFnrmicro1707_CR40","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1128\/AAC.48.10.3858-3870.2004","volume":"48","author":"J Balzarini","year":"2004","unstructured":"Balzarini, J. et al. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrob. Agents Chemother. 48, 3858\u20133870 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro1707_CR41","doi-asserted-by":"publisher","first-page":"41005","DOI":"10.1074\/jbc.M508801200","volume":"280","author":"J Balzarini","year":"2005","unstructured":"Balzarini, J. et al. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV gp120. A new therapeutic concept to hit the Achilles heel of HIV. J. Biol. Chem. 280, 41005\u201341014 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbpc.2005.10.019","volume":"142","author":"JH Wang","year":"2005","unstructured":"Wang, J. H. et al. A \u03b2-galactose-specific lectin isolated from the marine worm Chaetopterus variopedatus possesses anti-HIV-1 activity. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 142, 111\u2013117 (2005).","journal-title":"Comp. Biochem. Physiol. C. Toxicol. Pharmacol."},{"key":"BFnrmicro1707_CR43","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1128\/AEM.72.4.2950-2956.2006","volume":"72","author":"S Bulgheresi","year":"2006","unstructured":"Bulgheresi, S. et al. A new C-type lectin similar to the human immunoreceptor DC-SIGN mediates symbiont acquisition by a marine nematode. Appl. Environ. Microbiol. 72, 2950\u20132956 (2006).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrmicro1707_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molimm.2004.06.015","volume":"42","author":"X Ji","year":"2005","unstructured":"Ji, X., Gewurz, H. & Spear, G. T. Mannose-binding lectin (MBL) and HIV. Mol. Immunol. 42, 145\u2013152 (2005).","journal-title":"Mol. Immunol."},{"key":"BFnrmicro1707_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.molimm.2004.12.006","volume":"42","author":"NJ Klein","year":"2005","unstructured":"Klein, N. J. Mannose-binding lectin: do we need it? Mol. Immunol. 42, 919\u2013924 (2005).","journal-title":"Mol. Immunol."},{"key":"BFnrmicro1707_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","volume":"100","author":"TB Geijtenbeek","year":"2000","unstructured":"Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575\u2013585 (2000).","journal-title":"Cell"},{"key":"BFnrmicro1707_CR47","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","volume":"100","author":"TB Geijtenbeek","year":"2000","unstructured":"Geijtenbeek, T. B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587\u2013597 (2000).","journal-title":"Cell"},{"key":"BFnrmicro1707_CR48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/nsmb1005-830","volume":"12","author":"K Drickamer","year":"2006","unstructured":"Drickamer, K. & Taylor, M. E. Targeting diversity. Nature Struct. Mol. Biol. 12, 830\u2013831 (2006).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnrmicro1707_CR49","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","volume":"76","author":"CN Scanlan","year":"2002","unstructured":"Scanlan, C. N. et al. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of \u03b11\u21922 mannose residues on the outer face of gp120. J. Virol. 76, 7306\u20137321 (2002).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR50","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/jvi.70.2.1100-1108.1996","volume":"70","author":"A Trkola","year":"1996","unstructured":"Trkola, A. et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100\u20131108 (1996).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR51","doi-asserted-by":"publisher","first-page":"13372","DOI":"10.1073\/pnas.0505763102","volume":"102","author":"DA Calarese","year":"2005","unstructured":"Calarese, D. A. et al. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIVHIV-1 antibody 2G12. Proc. Natl Acad. Sci. USA 102, 13372\u201313377 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro1707_CR52","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","volume":"76","author":"RW Sanders","year":"2002","unstructured":"Sanders, R. W. et al. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76, 7293\u20137305 (2002).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR53","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1126\/science.1083182","volume":"300","author":"DA Calarese","year":"2003","unstructured":"Calarese, D. A. et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065\u20132071 (2003).","journal-title":"Science"},{"key":"BFnrmicro1707_CR54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.virol.2006.10.027","volume":"360","author":"D Huskens","year":"2007","unstructured":"Huskens, D., Van Laethem, K., Vermeire, K., Balzarini, J. & Schols, D. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. Virology 360, 294\u2013304 (2007).","journal-title":"Virology"},{"key":"BFnrmicro1707_CR55","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.7164\/antibiotics.41.1701","volume":"41","author":"T Oki","year":"1988","unstructured":"Oki, T. et al. Pradimicin, a novel class of potent antifungal antibiotics. J. Antibiot. 41, 1701\u20131704 (1988).","journal-title":"J. Antibiot."},{"key":"BFnrmicro1707_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7164\/antibiotics.46.465","volume":"46","author":"T Ueki","year":"1993","unstructured":"Ueki, T., Oka, M., Fukagawa, Y. & Oki, T. Studies on the mode of antifungal action of pradimicin antibiotics. III. Spectrophotometric sequence analysis of the ternary complex formation of BMY-28864 with D-mannopyranoside and calcium. J. Antibiot. (Tokyo) 46, 465\u2013477 (1993).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFnrmicro1707_CR57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7164\/antibiotics.41.807","volume":"41","author":"T Takeuchi","year":"1988","unstructured":"Takeuchi, T. et al. New antifungal antibiotics, benanomicins A and B from an actinomycete. J. Antibiot. (Tokyo) 41, 807\u2013811 (1988).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFnrmicro1707_CR58","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7164\/antibiotics.42.344","volume":"42","author":"H Hoshino","year":"1989","unstructured":"Hoshino, H., Seki, J. & Takeuchi, T. New antifungal antibiotics, benanomicins A and B inhibit infection of T-cell with human immunodeficiency virus (HIV) and syncytium formation by HIV. J. Antibiot. (Tokyo) 42, 344\u2013346 (1989).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFnrmicro1707_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0042-6822(90)90016-K","volume":"176","author":"A Tanabe-Tochikura","year":"1990","unstructured":"Tanabe-Tochikura, A., Tochikura, T. S, Yoshida, O., Oki, T., Yamamoto, N. Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan. Virology 176, 467\u2013473 (1990).","journal-title":"Virology"},{"key":"BFnrmicro1707_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/JVI.01404-06","volume":"81","author":"J Balzarini","year":"2007","unstructured":"Balzarini, J. et al. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. J. Virol. 81, 362\u2013373 (2007). The first demonstration that a small-size non-peptidic carbohydrate-recognizing antibiotic can force HIV to delete part of the protecting glycan shield on its envelope.","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR61","doi-asserted-by":"publisher","first-page":"11518","DOI":"10.1021\/ja035561f","volume":"125","author":"S Striegler","year":"2003","unstructured":"Striegler, S. & Dittel, M. A sugar discriminating binuclear copper (II) complex. J. Am. Chem. Soc. 125, 11518\u201311524 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnrmicro1707_CR62","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1021\/ja043037i","volume":"127","author":"M Mazik","year":"2005","unstructured":"Mazik, M., Cavqa, H. & Jones, P. G. Molecular recognition of carbohydrates with artificial receptors: mimicking the binding motifs found in the crystal structures of protein-carbohydrate complexes. J. Am. Chem. Soc. 127, 9045\u20139052 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnrmicro1707_CR63","doi-asserted-by":"publisher","first-page":"16088","DOI":"10.1074\/jbc.M200493200","volume":"277","author":"KK Ng","year":"2002","unstructured":"Ng, K. K. et al. Orientation of bound ligands in mannose-binding proteins. Implications for multivalent ligand recognition. J. Biol. Chem. 277, 16088\u201316095 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pbiomolbio.2004.05.001","volume":"88","author":"I Botos","year":"2005","unstructured":"Botos, I. & Wlodawer, A. Proteins that bind high-mannose sugars of the HIV-1 envelope. Prog. Biophys. Mol. Biol. 88, 233\u2013282 (2005). An extensive and detailed overview of carbohydrate-binding proteins that interact with the HIV envelope glycoprotein gp120.","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"BFnrmicro1707_CR65","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1126\/science.1066371","volume":"294","author":"H Feinberg","year":"2001","unstructured":"Feinberg, H., Mitchell, D. A., Drickamer, K. & Weis, W. I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294, 2163\u20132166 (2001).","journal-title":"Science"},{"key":"BFnrmicro1707_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/jmbi.1999.2862","volume":"290","author":"MK Sauerborn","year":"1999","unstructured":"Sauerborn, M. K., Wright, L. M., Reynolds, C. D., Grossmann, J. G. & Rizkallah, P. J. Insights into carbohydrate recognition by Narcissus pseudonarcissus lectin: the crystal structure at 2 \u00c5 resolution in complex with \u03b11\u20133 mannobiose. J. Mol. Biol. 290, 185\u2013199 (1999).","journal-title":"J. Mol. Biol."},{"key":"BFnrmicro1707_CR67","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nsb0695-472","volume":"2","author":"G Hester","year":"1995","unstructured":"Hester, G., Kaku, H., Goldstein, I. J. & Wright C. S. Strucure of mannose-specific snowdrop (Galanthus nivalis) lectin is representative of a new plant lectin family. Nature Struct. Biol. 2, 472\u2013479 (1995).","journal-title":"Nature Struct. Biol."},{"key":"BFnrmicro1707_CR68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.18388\/abp.2007_3282","volume":"54","author":"J Liu","year":"2007","unstructured":"Liu, J. et al. A novel tetrameric lectin from Lycoris aurea with four mannose binding sites per monomer. Acta Biochim. Pol. 54, 159\u2013166 (2007).","journal-title":"Acta Biochim. Pol."},{"key":"BFnrmicro1707_CR69","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1128\/JVI.00369-06","volume":"80","author":"J Balzarini","year":"2006","unstructured":"Balzarini, J. et al. Mutational pathways, resistance profile, and side effects of Cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes. J. Virol. 80, 8411\u20138421 (2006).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR70","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1084\/jem.164.6.2101","volume":"164","author":"J Lifson","year":"1986","unstructured":"Lifson, J., Coutre, S., Huang, E. & Engleman, E. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV-1) infectivity and virus-induced cell fusion. J. Exp. Med. 164, 2101\u20132106 (1986).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro1707_CR71","doi-asserted-by":"publisher","first-page":"13519","DOI":"10.1128\/JVI.79.21.13519-13527.2005","volume":"79","author":"SG Turville","year":"2005","unstructured":"Turville, S. G., Vermeire, K., Balzarini, J. & Schols, D. Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer. J. Virol. 79, 13519\u201313527 (2005).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.antiviral.2006.02.004","volume":"71","author":"J Balzarini","year":"2006","unstructured":"Balzarini, J. Inhibition of HIV entry by carbohydrate-binding proteins. Antiviral Res. 71, 237\u2013247 (2006).","journal-title":"Antiviral Res."},{"key":"BFnrmicro1707_CR73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1124\/mol.106.030155","volume":"71","author":"J Balzarini","year":"2007","unstructured":"Balzarini, J., Van Herrewege, Y., Vermeire, K., Vanham, G. & Schols, D. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIVHIV-1-1 transmission to T-lymphocytes. Mol. Pharmacol. 71, 3\u201311 (2007).","journal-title":"Mol. Pharmacol."},{"key":"BFnrmicro1707_CR74","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nri1182","volume":"3","author":"Y Van Kooyk","year":"2003","unstructured":"Van Kooyk, Y. & Geijtenbeek, T. B. DC-SIGN: escape mechanism for pathogens. Nature Rev. Immunol. 3, 697\u2013709 (2003).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro1707_CR75","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(05)70271-1","volume":"5","author":"J Balzarini","year":"2007","unstructured":"Balzarini, J. & Van Damme, L. Anti-human immunodeficiency virus (HIV-1) microbicide drug candidates to prevent HIV infection. Lancet 5, 726\u2013731 (2007).","journal-title":"Lancet"},{"key":"BFnrmicro1707_CR76","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1128\/JVI.02572-06","volume":"81","author":"N Izquierdo-Useros","year":"2007","unstructured":"Izquierdo-Useros, N. et al. Maturation of blood derived dendritic cells enhances HIV-1 capture and transmission. J. Virol. 81, 7559\u20137570 (2007).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR77","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1128\/JVI.01661-06","volume":"81","author":"C Boggiano","year":"2007","unstructured":"Boggiano, C., Manel, N. & Littman, D. R. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 81, 2519\u20132523 (2007).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR78","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1128\/JVI.01970-06","volume":"81","author":"JH Wang","year":"2007","unstructured":"Wang, J. H., Janas, A. M., Olson, W. J., KewalRamani, V. N. & Wu, L. CD4 co-expression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J. Virol. 81, 2497\u20132507 (2007).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR79","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm1541","volume":"13","author":"L de Witte","year":"2007","unstructured":"de Witte, L. et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nature Med. 13, 367\u2013371 (2007).","journal-title":"Nature Med."},{"key":"BFnrmicro1707_CR80","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1126\/science.1083182","volume":"300","author":"DA Calarese","year":"2003","unstructured":"Calarese, D. A. et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065\u20132071 (2003).","journal-title":"Science"},{"key":"BFnrmicro1707_CR81","doi-asserted-by":"crossref","unstructured":"Dwek, R. A. Glycobiology at Oxford. A personal view. The Biochemist 4\u20136 (2006).","DOI":"10.1042\/BIO02803004"},{"key":"BFnrmicro1707_CR82","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.febslet.2007.04.039","volume":"581","author":"J Balzarini","year":"2007","unstructured":"Balzarini, J. The \u03b1(1, 2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120. FEBS Lett. 581, 2060\u20132064 (2007).","journal-title":"FEBS Lett."},{"key":"BFnrmicro1707_CR83","doi-asserted-by":"publisher","first-page":"12575","DOI":"10.1128\/JVI.79.19.12575-12583.2005","volume":"79","author":"C Pikora","year":"2005","unstructured":"Pikora, C., Wittish, C. & Desrosiers, R. C. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4. J. Virol. 79, 12575\u201312583 (2005).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR84","doi-asserted-by":"publisher","first-page":"10617","DOI":"10.1128\/JVI.78.19.10617-10627.2004","volume":"78","author":"J Balzarini","year":"2004","unstructured":"Balzarini, J. et al. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. J. Virol. 78, 10617\u201310626 (2004).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR85","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1124\/mol.104.005082","volume":"67","author":"J Balzarini","year":"2005","unstructured":"Balzarini, J. et al. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Mol. Pharmacol. 67, 1556\u20131565 (2005).","journal-title":"Galanthus nivalis. Mol. Pharmacol."},{"key":"BFnrmicro1707_CR86","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1128\/JVI.79.12.7777-7784.2005","volume":"79","author":"M Witvrouw","year":"2005","unstructured":"Witvrouw, M. et al. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents Cyanovirin N and Concanavalin A. J. Virol. 79, 7777\u20137784 (2005).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR87","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","volume":"265","author":"CK Leonard","year":"1990","unstructured":"Leonard, C. K. et al. Assignment of intrachain disulphide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10373\u201310382 (1990).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR88","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/aid.1995.11.191","volume":"11","author":"WR Gallaher","year":"1995","unstructured":"Gallaher, W. R. et al. A general model for the surface glycoproteins of HIV-1 and other retroviruses. AIDS Res. Hum. Retroviruses 11, 191\u2013202 (1995).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnrmicro1707_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0264-410X(01)00358-9","volume":"20","author":"A Bolmstedt","year":"2001","unstructured":"Bolmstedt, A. et al. Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 306 glycan. Vaccine 20, 397\u2013405 (2001).","journal-title":"Vaccine"},{"key":"BFnrmicro1707_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.virol.2004.10.005","volume":"331","author":"SM Kang","year":"2005","unstructured":"Kang, S. M. et al. Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. Virology 331, 20\u201332 (2005).","journal-title":"Virology"},{"key":"BFnrmicro1707_CR91","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1128\/jvi.71.10.7719-7727.1997","volume":"71","author":"B Chackerian","year":"1997","unstructured":"Chackerian, B., Rundensey, L. M. & Overbaugh, J. Specific N-linked and O-linked glycosylation modifications in the envelope VI domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71, 7719\u20137727 (1997).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR92","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1128\/JVI.73.7.5294-5300.1999","volume":"73","author":"C Cheng-Mayer","year":"1999","unstructured":"Cheng-Mayer, C., Brown, A., Harouse, J., Luciw, P. A. & Mayer, A. J. Selection for neutralization resistance of the simian human immunodeficiency virus sHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73, 5294\u20135300 (1999).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR93","doi-asserted-by":"publisher","first-page":"9993","DOI":"10.1128\/JVI.77.18.9993-10003.2003","volume":"77","author":"WE Johnson","year":"2003","unstructured":"Johnson, W. E. et al. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J. Virol. 77, 9993\u201310003 (2003).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR94","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1128\/JVI.78.3.1525-1539.2004","volume":"78","author":"KS Cole","year":"2004","unstructured":"Cole, K. S., Steckbeck, J. D., Rowles, J. L., Desrosiers, R. C. & Montelaro, R. C. Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3. J. Virol. 78, 1525\u20131539 (2004).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR95","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm0698-679","volume":"4","author":"JN Reitter","year":"1998","unstructured":"Reitter, J. N., Means, R. E. & Desrosiers, R. C. A role for carbohydrates in immune evasion in AIDS. Nature Med. 4, 679\u2013684 (1998). Proof of the concept that SIV-containing glycan envelope deletions are more efficiently neutralized by the immune system than the wild-type virus.","journal-title":"Nature Med."},{"key":"BFnrmicro1707_CR96","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/JVI.80.2.999-1014.2006","volume":"80","author":"WM Blay","year":"2006","unstructured":"Blay, W. M. et al. Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian\/human immunodeficiency virus-infected macaques. J. Virol. 80, 999\u20131014 (2006).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR97","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1371\/journal.pcbi.0030011","volume":"3","author":"AFY Poon","year":"2007","unstructured":"Poon, A. F. Y., Lewis, F. I., Kosakovsky Pond, S. L. & Frost, S. D. W. Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope. PLoS Comput. Biol. 3, e11 (2007).","journal-title":"PLoS Comput. Biol."},{"key":"BFnrmicro1707_CR98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1462-5822.2004.00480.x","volume":"7","author":"EA Koppel","year":"2005","unstructured":"Koppel, E. A., van Gisbergen, K. P. J. M., Geijtenbeek, T. B. H. & van Kooyk, Y. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell Microbiol. 7, 157\u2013165 (2005).","journal-title":"Cell Microbiol."},{"key":"BFnrmicro1707_CR99","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.20021840","volume":"197","author":"B Tassaneetrithep","year":"2003","unstructured":"Tassaneetrithep, B. et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823\u2013829 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro1707_CR100","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1074-7613(02)00447-8","volume":"17","author":"F Halary","year":"2002","unstructured":"Halary, F. et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17, 653\u2013654 (2002).","journal-title":"Immunity"},{"key":"BFnrmicro1707_CR101","doi-asserted-by":"publisher","first-page":"32035","DOI":"10.1074\/jbc.M402296200","volume":"279","author":"PY Lozach","year":"2004","unstructured":"Lozach, P. Y. et al. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J. Biol. Chem. 279, 32035\u201332045 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR102","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","volume":"76","author":"CP Alvarez","year":"2002","unstructured":"Alvarez, C. P. et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841\u20136844 (2002).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR103","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","volume":"78","author":"A Marzi","year":"2004","unstructured":"Marzi, A. et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78, 12090\u201312095 (2004).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR104","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20021229","volume":"197","author":"TB Geijtenbeek","year":"2003","unstructured":"Geijtenbeek, T. B. et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197, 7\u201317 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro1707_CR105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1084\/jem.20021468","volume":"197","author":"L Tailleux","year":"2003","unstructured":"Tailleux, L. et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121\u2013127 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro1707_CR106","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jaci.2005.03.036","volume":"115","author":"HH Smits","year":"2005","unstructured":"Smits, H. H. et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115, 1260\u20131267 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrmicro1707_CR107","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.imbio.2005.05.014","volume":"210","author":"EA Koppel","year":"2005","unstructured":"Koppel, E. A., Saeland, E., de Cooker, D. J., van Kooyk, Y. & Geijtenbeek, T. B. DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14. Immunobiology 210, 203\u2013210 (2005).","journal-title":"Immunobiology"},{"key":"BFnrmicro1707_CR108","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4049\/jimmunol.170.4.1635","volume":"170","author":"BJ Appelmelk","year":"2003","unstructured":"Appelmelk, B. J. et al. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170, 1635\u20131639 (2003). References 46 and 47 provide the first identification of the impsortant role of the natural C-type lectin DC-SIGN in innate pathogen recognition, capture and antigen presentation to the immune system, whereas 38, 74 and 108 provide a comprehensive overview on this issue.","journal-title":"J. Immunol."},{"key":"BFnrmicro1707_CR109","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/glycob\/cwg052","volume":"13","author":"I van Die","year":"2003","unstructured":"van Die, I. et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 13, 471\u2013478 (2003).","journal-title":"Glycobiology"},{"key":"BFnrmicro1707_CR110","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.20041061","volume":"200","author":"MP Bergman","year":"2004","unstructured":"Bergman, M. P. et al. Helicobacter pylori modulates the T helper cell 1\/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200, 979\u2013990 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro1707_CR111","doi-asserted-by":"publisher","first-page":"37349","DOI":"10.1074\/jbc.M507100200","volume":"280","author":"S Meyer","year":"2005","unstructured":"Meyer, S. et al. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. J. Biol. Chem. 280, 37349\u201337359 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR112","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307\u2013312 (2003). Demonstration of the crucial importance of how a continuously evolving glycan shield on the HIV envelope gp120 escapes immune surveillance in HIV-infected individuals.","journal-title":"Nature"},{"key":"BFnrmicro1707_CR113","doi-asserted-by":"publisher","first-page":"25177","DOI":"10.1074\/jbc.M602431200","volume":"281","author":"F Helle","year":"2006","unstructured":"Helle, F. et al. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J. Biol. Chem. 281, 25177\u201325183 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro1707_CR114","unstructured":"Bertaux, C. et al. The inhibition of infection and entry of the human immunodeficiency virus (HIVHIV-1) and hepatitis C virus (HCV) closely correlates for carbohydrate-binding agents (CBA), but not for polyanions. Virology (in the press). Together with reference 113, this reference gives the first demonstration that a CBA can inhibit human hepatitis C virus."},{"key":"BFnrmicro1707_CR115","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.antiviral.2007.03.003","volume":"75","author":"E Keyaerts","year":"2007","unstructured":"Keyaerts, E. et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 75, 179\u2013187 2007.","journal-title":"Antiviral Res."},{"issue":"1","key":"BFnrmicro1707_CR116","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2007.04.003","volume":"76","author":"F VANDERMEER","year":"2007","unstructured":"Van der Meer, F. et al. Antiviral activity of carbohydrate-binding agents against nidovirales in cell culture. Antiviral Res. 21 May 2007 (doi:10.1016\/j.antiviral.2007.04.003).","journal-title":"Antiviral Research"},{"key":"BFnrmicro1707_CR117","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0166-3542(02)00183-3","volume":"58","author":"LG Barrientos","year":"2003","unstructured":"Barrientos, L. G. et al. Cyanovirin-N binds to the viral surface glycoprotein, GP1, 2 and inhibits infectivity of Ebola virus. Antiviral Res. 58, 47\u201356 (2003).","journal-title":"Antiviral Res."},{"key":"BFnrmicro1707_CR118","first-page":"25","volume-title":"Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections","author":"D Huskens","year":"2007","unstructured":"Huskens, D., Vandemeulebroucke, E., Willaert, X., Balzarini, J. & Schols, D. Safety concerns for the potential use of cyanovirin as a microbicidal anti-HIV agent in Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, USA, 25\u201328 February 2007."},{"key":"BFnrmicro1707_CR119","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1126\/science.291.5512.2370","volume":"291","author":"PM Rudd","year":"2001","unstructured":"Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A. & Dwek, R. A. Glycosylation and the immune system. Science 291, 2370\u20132376 (2001).","journal-title":"Science"},{"key":"BFnrmicro1707_CR120","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nri1960","volume":"6","author":"L Wu","year":"2006","unstructured":"Wu, L. & KewalRamani, N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nature Rev. Immunol. 6, 859\u2013868 (2006).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro1707_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/095632020701800101","volume":"18","author":"J Balzarini","year":"2007","unstructured":"Balzarini, J. Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? Antivir. Chem. Chemother. 18, 1\u201311 (2007).","journal-title":"Antivir. Chem. Chemother."},{"key":"BFnrmicro1707_CR122","volume-title":"Dendritic cell-mediated HIV-1 transmission","author":"F Groot","year":"2006","unstructured":"Groot, F. Dendritic cell-mediated HIV-1 transmission. Thesis, Univ. Amsterdam (2006)."},{"key":"BFnrmicro1707_CR123","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/31405","volume":"393","author":"PD Kwong","year":"1998","unstructured":"Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648\u2013659 (1998). The first crystallographic structure of the HIV envelope gp120.","journal-title":"Nature"},{"key":"BFnrmicro1707_CR124","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.1128\/JVI.78.15.8322-8332.2004","volume":"78","author":"JS Ludwig","year":"2004","unstructured":"Ludwig, J. S. et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J. Virol. 78, 8322\u20138332 (2004).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR125","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/JVI.80.3.1290-1301.2006","volume":"80","author":"CW Davis","year":"2006","unstructured":"Davis, C. W. et al. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 80, 1290\u20131301 (2006).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR126","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/14728222.6.4.423","volume":"6","author":"F Baribaud","year":"2002","unstructured":"Baribaud, F., Doms, R. W. & Pohlmann, S. The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? Expert Opin. Ther. Targets 6, 423\u2013431 (2002).","journal-title":"Expert Opin. Ther. Targets"},{"key":"BFnrmicro1707_CR127","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.176.3.1741","volume":"176","author":"G Rappocciolo","year":"2006","unstructured":"Rappocciolo, G. et al. DC-SIGN is a receptor for human herpes virus 8 on dendritic cells and macrophages. J. Immunol. 176, 1741\u20131749 (2006).","journal-title":"J. Immunol."},{"key":"BFnrmicro1707_CR128","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1128\/JVI.80.7.3477-3486.2006","volume":"80","author":"L de Witte","year":"2006","unstructured":"de Witte, L., Abt, M., Schneider-Schaulies, S., von Kooyk, Y. & Geijtenbeek, T. B. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 80, 3477\u20133486 (2006).","journal-title":"J. Virol."},{"key":"BFnrmicro1707_CR129","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.humimm.2006.02.028","volume":"67","author":"LB Barreiro","year":"2006","unstructured":"Barreiro, L. B. et al. DC-SIGN interacts with Mycobacterium leprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population. Hum. Immunol. 67, 102\u2013107 (2006).","journal-title":"Hum. Immunol."},{"key":"BFnrmicro1707_CR130","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.imbio.2005.05.013","volume":"210","author":"E Caparros","year":"2005","unstructured":"Caparros, E. et al. Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes. Immunobiology 210, 185\u2013193 (2005).","journal-title":"Immunobiology"},{"key":"BFnrmicro1707_CR131","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.imbio.2005.05.011","volume":"210","author":"D Serrano-Gomez","year":"2005","unstructured":"Serrano-Gomez, D., Leal, J. A. & Corbi, A. L. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology 210, 175\u2013183 (2005).","journal-title":"Immunobiology"},{"key":"BFnrmicro1707_CR132","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/immu.200310029","volume":"33","author":"A Cambi","year":"2003","unstructured":"Cambi, A. et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33, 532\u2013538 (2003).","journal-title":"Eur. J. Immunol."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrmicro1707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrmicro1707","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrmicro1707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:33:49Z","timestamp":1744284829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro1707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["BFnrmicro1707"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro1707","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}